Spinal neurokinin3 receptors mediate thermal but not mechanical hyperalgesia via nitric oxide

被引:23
作者
Linden, DR
Seybold, VS
机构
[1] Univ Minnesota, Program Neurosci, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Dept Cell Biol & Neuroanat, Minneapolis, MN 55455 USA
关键词
NK3; receptor; neurokinin; spinal cord; hyperalgesia; nociception; rat;
D O I
10.1016/S0304-3959(98)00222-X
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Although intrathecally administered senktide, an agonist at the neurokinin(3) receptor, attenuates withdrawal responses to noxious stimuli in the restrained animal, senktide increases motor neuron activity in spinal cords of neonatal rats and facilitates the electrically-evoked nociceptive flexor reflex in the adult rat. The present study examined the effects of intrathecal administration of senktide on withdrawal responses ro noxious thermal and mechanical stimuli in awake, unrestrained, adult rats. Intrathecal administration of senktide (10 nmol) in chronically catheterized rats did not alter the responses elicited by a noxious mechanical stimulus (508 mN, von Frey monofilament). Conversely, intrathecal senktide (10 nmol) induced thermal hyperalgesia, indicated by decreased withdrawal latency to radiant heat. Thermal hyperalgesia peaked 20-26 min following drug injection and returned to normal within 30 min. SR 142801 (60 nmol), a nonpeptide neurokinin(3) receptor antagonist, inhibited the senktide-induced hyperalgesia, providing further support that the effect of senktide is mediated by neurokinin3 receptors. Pretreatment with NG-nitro-L-arginine methyl ester (30 nmol), a nitric oxide synthase inhibitor, blocked the effect of senktide, indicating that senktide-induced thermal hyperalgesia is also mediated by the production of nitric oxide. Intrathecal senktide produced vasodilation and increased skin temperature in the hind paw. Intravenous hexamethonium, a ganglionic nicotinic receptor antagonist, similarly increased paw temperature without decreasing withdrawal latency to radiant heat. Thus, the increased skin temperature associated with intrathecal senktide was insufficient to account for the thermal hyperalgesia observed. Collectively, the present work demonstrates that NK3 receptors mediate thermal but not mechanical hyperalgesia through a pathway that involves the production of NO. (C) 1999 International Association for the Study of Pain. Published by Elsevier Science B.V.
引用
收藏
页码:309 / 317
页数:9
相关论文
共 40 条
[1]   RESPONSE LATENCIES IN THE TAIL-FLICK TEST DEPEND ON TAIL SKIN TEMPERATURE [J].
BERGE, OG ;
GARCIACABRERA, I ;
HOLE, K .
NEUROSCIENCE LETTERS, 1988, 86 (03) :284-288
[2]  
Canning BJ, 1998, J PHARMACOL EXP THER, V284, P370
[3]   RECEPTOR CHARACTERIZATION OF THE SPINAL ACTION OF NEUROKININS ON NOCICEPTION - A 3 RECEPTOR HYPOTHESIS [J].
COUTURE, R ;
BOUCHER, S ;
PICARD, P ;
REGOLI, D .
REGULATORY PEPTIDES, 1993, 46 (1-2) :426-429
[4]   Characterization of variables defining hindpaw withdrawal latency evoked by radiant thermal stimuli [J].
Dirig, DM ;
Salami, A ;
Rathbun, ML ;
Ozaki, GT ;
Yaksh, TL .
JOURNAL OF NEUROSCIENCE METHODS, 1997, 76 (02) :183-191
[5]   MULTIPLE TYPES OF TACHYKININ RECEPTOR MEDIATE A SLOW EXCITATION OF RAT SPINAL MOTONEURONS IN-VITRO [J].
FISHER, ND ;
BARANAUSKAS, G ;
NISTRI, A .
NEUROSCIENCE LETTERS, 1994, 165 (1-2) :84-88
[6]   UNMYELINATED NOCICEPTIVE UNITS IN 2 SKIN AREAS OF THE RAT [J].
FLEISCHER, E ;
HANDWERKER, HO ;
JOUKHADAR, S .
BRAIN RESEARCH, 1983, 267 (01) :81-92
[7]  
Fox AJ, 1996, ACTA BIOL HUNG, V47, P129
[8]   DEPRESSION OF PRIMARY AFFERENT-EVOKED RESPONSES BY GR71251 IN THE ISOLATED SPINAL-CORD OF THE NEONATAL RAT [J].
GUO, JZ ;
YOSHIOKA, K ;
YANAGISAWA, M ;
HOSOKI, R ;
HAGAN, RM ;
OTSUKA, M .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) :1142-1148
[9]   A NEW AND SENSITIVE METHOD FOR MEASURING THERMAL NOCICEPTION IN CUTANEOUS HYPERALGESIA [J].
HARGREAVES, K ;
DUBNER, R ;
BROWN, F ;
FLORES, C ;
JORIS, J .
PAIN, 1988, 32 (01) :77-88
[10]   CARDIOVASCULAR-RESPONSES INDUCED BY INTRATHECAL SUBSTANCE-P IN THE CONSCIOUS FREELY MOVING RAT [J].
HASSESSIAN, H ;
COUTURE, R .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1989, 13 (04) :594-602